OncoMed Pharmaceuticals, Inc. Recaps New Data Presented at American Association for Cancer Research
REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals, Inc., a privately held, clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor initiating cells, today highlighted new data presented this week in an oral presentation and three posters at the Annual Meeting of the American Association for Cancer Research (AACR) in Chicago, IL.